RFK Jr. removes all members of CDC vaccine advisory committee
Health Secretary Robert F. Kennedy Jr. on Monday removed every member of the Centers for Disease Control and Prevention's (CDC) scientific vaccine advisory committee and pledged to replace them with his own picks.
The move to oust all 17 members of the Advisory Committee on Immunisation Practices was condemned by major physicians' groups.
Before becoming America's top health official, Kennedy was one of the nation's biggest anti-vaccine activists. RFK Jr has not yet revealed who he would appoint to the panel, but said that it would convene in just two weeks in Atlanta.
'Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028,' Kennedy wrote, adding that "a clean sweep is needed to re-establish public confidence in vaccine science."
Kennedy had recently said that the committee members had too many conflicts of interest. The panel members routinely disclose any conflicts at the start of public meetings.
Dr. Georges Benjamin, executive director of the American Public Health Association, termed Kennedy's mass ouster of the panel as "a coup".
'It's not how democracies work. It's not good for the health of the nation,' he told The Associated Press.
Benjamin said that the move raises real concerns about whether the future members of the vaccine advisory committee will be seen as impartial.
He said that Kennedy "is breaking a promise", adding that "he said he wasn't going to do this".
Dr Bruce A Scott, president of the American Medical Association, called the panel a trusted source of science and data-driven advice, adding that Kennedy's move will increase the number of diseases that can be prevented by vaccines.
'Today's action to remove the 17 sitting members of ACIP undermines that trust and upends a transparent process that has saved countless lives,' Scott said in a statement.
Kennedy Jr recently also took the unusual step of changing the Covid-19 recommendations, without first consulting the panel.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
30 minutes ago
- Mint
US and China to resume trade talks in London amid rare earth export disputes
Top officials from the US and China will continue trade negotiations in London on Tuesday, aiming to resolve disputes over export controls on key goods like rare earth—materials vital to global industries. 1. Hopes for improved relations were reignited by a preliminary deal in Geneva last month but have since dimmed after the US accused China of restricting exports crucial to sectors such as automotive, aerospace, semiconductors, and defence, Reuters reported. 2. Moreover, investors are closely watching for signs of progress to avoid potential disruptions in the global supply chain and economic slowdown. The talks come at a crucial time for both economies, with customs data showing that China's exports to the US plunged 34.5% in May, the sharpest drop since February 2020, when the outbreak of the COVID-19 pandemic upended global trade. 3. Though the effects on US inflation and employment have been limited so far, the dollar continues to face pressure due to domestic policy concerns. US and Chinese officials convened at London's historic Lancaster House on Monday to address ongoing disagreements related to the Geneva trade agreement, Reuters reported. 4. The discussions are set to continue early Tuesday, with updates anticipated from both delegations afterwards. The US side is led by US Treasury Secretary Scott Bessent, Commerce Secretary Howard Lutnick and US Trade Representative Jamieson Greer, while the Chinese contingent is helmed by Vice Premier He Lifeng, Reuters reported. 5. The inclusion of Lutnick, whose agency oversees export controls for the U.S., is one indication of how central rare earths have become. China holds a near-monopoly on rare earth magnets, a crucial component in electric vehicle motors. Lutnick did not attend the Geneva talks at which the countries struck a 90-day deal to roll back some of the triple-digit tariffs they had placed on each other. 6. Trump's often erratic policymaking on tariffs has roiled global markets, sparked congestion and confusion in major ports, and cost companies tens of billions of dollars in lost sales and higher costs. The second round of meetings between the two sides comes four days after Trump and Xi spoke by phone, their first direct interaction since Trump's January 20 inauguration. Though the effects on US inflation and employment have been limited so far, the dollar continues to face pressure due to domestic policy concerns. 7. After a call with Trump, Chinese President Jinping agreed to restart rare earth mineral and magnet shipments to the US, with China granting temporary export licenses to suppliers serving the top three American automakers. However, despite this development, tensions remain elevated as factories worldwide continue to worry about potential shortages of critical materials needed to maintain operations. (With inputs from Reuters) Key Takeaways The resumption of talks highlights the importance of rare earth materials in global industries. China's near-monopoly on rare earths could pose significant risks to US economic interests. Ongoing trade disputes may impact global supply chains, causing potential shortages in key sectors.
Hindustan Times
an hour ago
- Hindustan Times
Ludhiana: 2 more test +ve for COVID, four recover
Two new COVID-19 positive cases were reported in the district on Monday, taking the tally to 23 cases. Four people who tested positive earlier were also reported to have recovered on Monday. The two 44-year-old and 50-year-old women who tested positive are reported to be only mildly symptomatic and in home isolation. Both have a travel history. The 44-year-old had recently made a trip to Haridwar while the other had gone to Delhi. Both were vaccinated for COVID-19. Earlier on Sunday there were no new cases reported in the district. Nine people who had reported positive earlier have finished their home quarantines and only 12 of the cases are active at present. One of the active cases is hospitalised while the rest are in home isolation. Two people have died of infection so far. Both of these were comorbid cases. Except an 18-year-old, all the people who were reported positive were vaccinated.
Hans India
an hour ago
- Hans India
New Covid variant XFG detected in 163 cases
New Delhi: A new Covid-19 variant known as XFG has been detected in 163 cases across India, according to the latest update from INSACOG, the Indian SARS-CoV-2 Genomics Consortium. A network of 54 laboratories across India that track how the virus that causes Covid-19 is changing, INSACOG plays a crucial role in flagging emerging variants so that public health systems can respond effectively. This comes at a time when active Covid-19 cases in the country are inching upwards, with over 6,000 active cases currently reported by the Union Health Ministry. What is XFG variant? XFG is a recombinant subvariant of the SARS-CoV-2 virus, which means it is formed by the mixing of two earlier variants, first detected in Canada. In this case, LF.7 and LP.8.1.2 have combined to form XFG. Recombinant variants emerge when a person is infected with two different strains of the virus simultaneously, and the virus "mixes and matches" its genetic material. XFG is classified under the larger Omicron family of Covid-19 variants, which has been dominant globally since late 2021. According to INSACOG's latest data: Maharashtra has recorded the highest number of XFG cases (89), followed by Tamil Nadu (16), Kerala (15), Gujarat (11), and Andhra Pradesh, Madhya Pradesh, and West Bengal (six each). Most of these cases (159) were detected in May 2024, while two each were reported in April and June. Indian scientists are closely watching XFG because of certain mutations in its spike protein, the part of the virus that helps it attach to and enter human cells. These include changes named His445Arg, Asn487Asp, Gln493Glu, and Thr572Ile, according to a report by The Lancet. These mutations may affect how easily the virus enters human cells, how well it evades the immune system, and how fast it spreads from person to person. While some of the changes reduce the virus's ability to latch onto human cells (what experts call reduced ACE2 receptor binding), others seem to help it evade immune responses, meaning it can escape detection by the body's natural defences or vaccines. This combination means that while XFG might not be as infectious as earlier strains, its immune evasion capabilities make it harder for the body to fight once infected, especially in people with weaker immunity or without updated vaccines. At the moment, there is no evidence to suggest that XFG is causing more severe illness or hospitalisations. However, its ability to spread quietly, by evading immunity, could make it a challenge if it becomes widespread. According to the Lancet report, XFG and other related emerging variants like NB.1.8.1, LF.7.9, and XFH show growth advantages, meaning they may be better at spreading than previous strains. These variants could potentially drive the next wave of infections if not monitored closely.
